The Korea Herald CENTER (0.0) Reliability: 7.0/10

SK Biopharm secures Actinium-225 supply in Europe with Eckert & Ziegler deal

✍️ Jang Hae-Rin 📅 December 03, 2025 06:04 AM ⏱️ 1 min read 🕐 Scraped: December 03, 2025

Summary: SK Biopharmaceuticals said Wednesday it has signed a supply agreement with Germany’s Eckert & Ziegler, a leading radioisotope company, to procure Actinium-225 —

SK Biopharmaceuticals said Wednesday it has signed a supply agreement with Germany’s Eckert & Ziegler, a leading radioisotope company, to procure Actinium-225 — a critical material used in next-generation cancer therapies.

The deal establishes a E

📰

Continue Reading on The Korea Herald

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Jang Hae-Rin

Original Publisher

🌍 The Korea Herald

CENTER Bias (0.0)

Published Date

December 03, 2025 at 06:04 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.